Zymewire Blog

by Ian Hamilton-Burge, Director of Customer Solutions

Review of 2022 Biopharma funding: How should sales teams at service providers adapt for 2023?

Agility to Fight a Recession: Emerging Biopharma’s Secret Weapon

04 Jan, 2023

by Alec de la Durantaye

Agility to Fight a Recession: Emerging Biopharma’s Secret Weapon

Why Your Cold Outreach to Biotechs is Failing… And How to Fix It

25 Oct, 2022

by Danika Miller-Bouchard

When it comes to cold outreach in the B2B context, one thing is certain: Email is still the dominant channel. Sales professionals at ...

More Signal, Less Noise: Announcing Muting Companies in Zymewire

12 Oct, 2022

by Ian Hamilton-Burge, Director of Customer Solutions

Noise is a Problem, Turn Down the Volume.

Reach your prospects the first time: Announcing improvements to Contact Search

14 Feb, 2022

by Ian Hamilton-Burge, Director of Customer Solutions

Laser-focused outreach outperforms generic messages and mass emails. That’s the guiding principle behind our update to Contact Search, ...

What’s the deal with NLP?

03 Dec, 2021

by Ian Hamilton-Burge, Director of Customer Solutions

Machine learning. Artificial intelligence. Predictive analytics.

Scott’s Sales Tales: What Can Sales Pros Learn from a Hot Dog Eating Champ?

27 Oct, 2021

by Scott Ballenger

For those that are new to the “Sales Tales,” we launched a series of posts here on the Zymewire blog that capture some of my favorite sales ...

How the Heck to Find Your Way Around the Cell and Gene Therapy Space

15 Oct, 2021

We know that the cell and gene therapy space is unique – and can be uniquely challenging to navigate, with specific quirks and nuances.

On the Virtual Road: Sales Tales with Scott Ballenger - Positioning

05 Oct, 2021

by Scott Ballenger

A few weeks ago, we launched a series of posts here on the Zymewire blog that encapsulate some of my favorite sales parables. In a ...

The Latest on Return to Business Travel

27 Sep, 2021

We had all hoped for far more certainty around travel this coming fall – but as the delta variant continues to wreak havoc around the ...

On the Virtual Road: Sales Tales with Scott Ballenger - One egg or two?

17 Sep, 2021

by Scott Ballenger

The pandemic has cost us many things, including, for too many of us, the ability to connect with our colleagues in person. At Zymewire, we ...

Remote Buying in a Virtual World: 6 Reflections from a Pharma Procurement Exec.

27 Aug, 2021

Recently, Zymewire’s Scott Ballenger had an opportunity to sit down with Stefanie Kuhner, an executive in the procurement department from ...

11 Insights to Help Build Great Partnerships with Cell & Gene Therapy Companies

16 Jun, 2021

by Ian Hamilton-Burge, Director of Customer Solutions

During our ongoing conversations with clients here at Zymewire, it became clear that cell and gene therapy companies were really heating up ...

Discovering Stealth Companies: Neuway Pharma from Bonn, Germany

16 Jun, 2021

by Sara El-Talmas, Zymewire

We’re looking at Neuway Pharma, a Europe-based biotech startup, in this edition of Sponsor Atlas series. This branch of the blog focuses ...

Selling to Biotech After the COVID Cliff

14 May, 2021

by Casey Enders

Are you wondering how the pandemic will change the biotech landscape and your prospecting work? We were, too – so we dug into the data and ...

Discovering Biotech Startups: A map for Selling to Vanguard Therapeutics

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Canget BioTekpharma: A One Pager for Selling to this Stealth Biotech Startup

This branch of our Sponsor Atlas series focuses on young pharmaceutical and biotechnology companies that are in early stages or stealth ...

Braizon Therapeutics: A Map for Selling to this Japanese Stealth Biotech Startup

In this edition of Sponsor Atlas: Discovering Biotech Startups, we’re looking at Braizon Therapeutics (Braizon). We will give a business ...

Mekanistic Therapeutics: A Map for Selling to this Stealth Biotech Startup

This branch of our Sponsor Atlas series focuses on young pharmaceutical and biotechnology companies that are in early stages or stealth ...

Sulfateq BV: A Map for Selling to this European Biotech Startup

In this edition of Sponsor Atlas: Discovering Biotech Startups, we are looking at Sulfateq BV (Sulfateq), exploring the current affairs and ...

Montisera: A Map for selling to this emerging European Biotech

This branch of our Sponsor Atlas series focuses on young pharmaceutical and biotechnology companies that are in early stages or stealth ...

Tiburio Therapeutics: A Map for Selling to this Stealth Biotech Startup

21 Oct, 2020

This branch of our Sponsor Atlas series focuses on young pharmaceutical and biotechnology companies that are in early stages or stealth ...

CPhI Festival of Pharma

01 Oct, 2020

After many discussions with key partners and industry stakeholders, the annual CPhI Worldwide (in-person) event is now confirmed to return ...

All About AbbVie: A map for Selling to AbbVie

30 Sep, 2020

Note: This article was originally written for 2019 publication, and has since been updated.

Discovering Biotech Startups: A map for Selling to Geneos Therapeutics

16 Sep, 2020

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Blueprint to Biogen: A map for Selling to Biogen

08 Sep, 2020

Note: This article was originally written for 2019 publication, and has since been updated.

Discovering Biotech Startups: A map for Selling to Pyxis Oncology

01 Sep, 2020

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Discovering Biotech Startups: A map for Selling to Felix Biotechnology

01 Sep, 2020

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Sales Intelligence Products: Things to Consider for Your Team

31 Aug, 2020

by Sean Cannon

In today’s world, many providers are claiming to be sales intelligence solutions. This statement is remarkably convoluted, as the category ...

Twentyeight-Seven Therapeutics: A One Pager for Selling to this Stealth Biotech Startup

17 Aug, 2020

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Discovering Biotech Startups: A Map for Selling to NanoCell Therapeutics

23 Jun, 2020

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Discovering Biotech Startups: A map for Selling to Symbiotica

23 Jun, 2020

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

DIA Global Annual Meeting 2020

12 Jun, 2020

In light of the recent pandemic that has spread throughout the world, it is with great excitement to know that much of the invaluable ...

Discovering Biotech Startups: A map for Selling to Snap Bio

03 Jun, 2020

This branch of our Sponsor Atlas series focuses on young pharmaceutical and biotechnology companies that are in early stages or stealth ...

Discovering Biotech Startups: A map for Selling to Intrepida Bio

03 Jun, 2020

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Discovering Biotech Startups: A map for Selling to Alaya Bioscience

03 Apr, 2020

We are moving right along with the new branch of the Sponsor Atlas series, which focuses on young pharmaceutical and biotechnology ...

Discovering Biotech Startups: A map for Selling to Avenzoar Pharmaceuticals

03 Apr, 2020

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

What do big pharma companies spend on research & development?

01 Apr, 2020

by Sean Cannon

We've been working hard on a new report, and today we're happy to share that it is now available through Outsourcing-Pharma! Our inaugural ...

Zymewire Launches Directory of Drug Development Experts with Services Available to Fight COVID-19

01 Apr, 2020

Company News

In these unprecedented times, the Zymewire team has been thinking deeply about ways in which we can contribute to the global fight against ...

Guide to Gilead: A map for Selling to Gilead Sciences

01 Apr, 2020

Note: This article was originally written for 2019 publication, and has since been updated.

Racolta: Cancelled and Postponed Conferences between March 15 - April 11 2020

13 Mar, 2020

by Racolta

Due to recent circumstances, the following conferences have released statements advising of changes to scheduled events. Please see ...

Decisions, Decisions: A map for Selling to Novartis

13 Mar, 2020

As a large, complex, multinational company, it isn’t all that obvious which decisions are made at which Novartis sites around the world. ...

DCAT Week 2020

11 Mar, 2020

Update: Unfortunately, due to the current COVID-19 situation, DCAT Week 2020 has officially been cancelled. At the time of publish, there ...

Discovering Biotech Startups: A map for Selling to Soteria Biotherapeutics

11 Mar, 2020

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Breaking into Bristol, Myers, AND Squibb: A map for Selling to Bristol-Myers Squibb

04 Mar, 2020

In this edition of Sponsor Atlas: Selling to the Pharma Giants, we're visiting New York City's biopharma behemoth, Bristol-Myers Squibb ...

Outsourcing in Pharma & Biotech: Shifting to Contract Manufacturing and Development

04 Mar, 2020

As the world’s population ages and healthcare standards continue to rise, the demand for pharmaceutical products has been steadily ...

Discovering Biotech Startups: A map for Selling to Nitrome Biosciences

04 Mar, 2020

Welcome to the next edition of the Sponsor Atlas series, which focuses on young pharmaceutical and biotechnology companies that are in ...

Activating Amgen: A map for Selling to Amgen

02 Mar, 2020

Amgen Inc. is one of the world’s 10 largest biopharmaceutical companies, founded and headquartered in California, USA. In 2018, Amgen ...

DIA Europe 2020

02 Mar, 2020